Startup Nawgen Looks to Develop Genome-wide microRNA Profiling Assays | GenomeWeb

NEW YORK (GenomeWeb) – With the proceeds of a recently awarded a one-year grant from the National Institutes of Health, startup Nawgen is aiming to develop a portfolio of real-time PCR assays for microRNA expression profiling covering the entire human and mouse genomes.

According to Xiaowei Wang, a researcher at Washington University in St. Louis who founded Nawgen, the assays are expected to be ready by early next year. The company is currently exploring its options for sales and marketing, including partnering with a bigger life sciences player, he added.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.